I'm guessing their Market Cap. will be reduced by more than the settlement amount by the end of the week all due to such an ambiguous announcement.This could of been positioned SO much better
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%